Polyclonal Antibody to BH3 Interacting Domain Death Agonist (Bid) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.
RPA629Mu02-Recombinant BH3 Interacting Domain Death Agonist (Bid)
Recommended Usage
Western blotting: 0.5-2µg/mL; Immunohistochemistry: 5-20µg/mL; Immunocytochemistry: 5-20µg/mL; Optimal working dilutions must be determined by end user.
